Decatecholaminisation of Septic Shock With Dexmedetomidine and In-hospital Mortality

NCT05283083 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Septic Shock
Sepsis

Interventions

DRUG: Dexmedetomidine

Sponsor

Mansoura University